Showing results (131-140 of 145) with videos related to
Sort By:
Pageof 15
Transplantation Proceedings|May 4, 2005
Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of cyclosporine, and basiliximabB K Krämer, H-H Neumayer, R Stahl, et al.Journal of Molecular Medicine (Berlin, Germany)|March 28, 2001
Impaired sodium excretion, decreased glomerular filtration rate and elevated blood pressure in endothelin receptor type B deficient ratsB Hocher, C Dembowski, T Slowinski, et al.Transplantation Proceedings|June 21, 2005
Laparoscopic versus open donor nephrectomy in Germany: impact on donor health-related quality of life and willingness to donateM Giessing, S Reuter, S Deger, et al.European Journal of Medical Research|March 5, 2009
Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathyL Kleeberg, S Morgera, C Jakob, et al.American Journal of Respiratory Cell and Molecular Biology|June 29, 2000
Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic miceB Hocher, A Schwarz, K A Fagan, et al.The Journal of Clinical Investigation|March 15, 1997
Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertensionB Hocher, C Thöne-Reineke, P Rohmeiss, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2012
Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantationL Liefeldt, S Brakemeier, P Glander, et al.Transplantation Proceedings|May 4, 2005
Cyclosporine C2 levels in de novo renal allograft recipients: a German multicenter prospective observational studyW Arns, F Zantvoort, D Abendroth, et al.Journal of the American College of Cardiology|May 12, 2000
Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized studyS B Felix, A Staudt, W V Dörffel, et al.The New England Journal of Medicine|May 13, 1999
Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study GroupD Lowance, H H Neumayer, C M Legendre, et al.Pageof 15